Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Complete Summary

GUIDELINE TITLE

ACR Appropriateness Criteria® breast microcalcifications.

BIBLIOGRAPHIC SOURCE(S)

  • D'Orsi C, Bassett LW, Berg WA, Bohm-Velez M, Evans WP III, Farria DM, Lee C, Mendelson E, Goldstein S, Expert Panel on Women's Imaging. Breast microcalcifications. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 12 p. [17 references]

GUIDELINE STATUS

This is the current release of the guideline.

It updates a previously published version: Cardenosa G, Mendelson E, Bassett L, Bohm-Velez M, D'Orsi C, Evans WP 3rd, Monsees B, Thurmond A, Goldstein S. Appropriate imaging work-up of breast microcalcifications. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 Jun;215 Suppl:973-80.

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

COMPLETE SUMMARY CONTENT

 
SCOPE
 METHODOLOGY - including Rating Scheme and Cost Analysis
 RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS
 QUALIFYING STATEMENTS
 IMPLEMENTATION OF THE GUIDELINE
 INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

SCOPE

DISEASE/CONDITION(S)

Breast microcalcifications

GUIDELINE CATEGORY

Diagnosis
Evaluation

CLINICAL SPECIALTY

Family Practice
Internal Medicine
Nuclear Medicine
Obstetrics and Gynecology
Oncology
Radiology

INTENDED USERS

Health Plans
Hospitals
Managed Care Organizations
Physicians
Utilization Management

GUIDELINE OBJECTIVE(S)

To evaluate the appropriateness of radiologic procedures for patients with breast microcalcifications

TARGET POPULATION

Women with breast microcalcifications

INTERVENTIONS AND PRACTICES CONSIDERED

  1. X-ray (mammography)
    • Magnification views & magnification views with 2 projections
    • Orthogonal views (90o lateral and cranial-caudal [CC] views if not readily available)
    • Tangential views, dermal localization exam
  2. Invasive procedures
    • Core biopsy
    • Excisional biopsy
    • Fine needle aspiration (FNA)
  3. Ultrasound (US)
  4. Magnetic resonance imaging (MRI)
  5. Physical examination
  6. Six month follow-up
  7. Nuclear medicine (NUC), sestamibi

MAJOR OUTCOMES CONSIDERED

Utility of radiologic examinations in differential diagnosis

METHODOLOGY

METHODS USED TO COLLECT/SELECT EVIDENCE

Searches of Electronic Databases

DESCRIPTION OF METHODS USED TO COLLECT/SELECT THE EVIDENCE

The guideline developer performed literature searches of peer-reviewed medical journals, and the major applicable articles were identified and collected.

NUMBER OF SOURCE DOCUMENTS

The total number of source documents identified as the result of the literature search is not known.

METHODS USED TO ASSESS THE QUALITY AND STRENGTH OF THE EVIDENCE

Weighting According to a Rating Scheme (Scheme Not Given)

RATING SCHEME FOR THE STRENGTH OF THE EVIDENCE

Not stated

METHODS USED TO ANALYZE THE EVIDENCE

Systematic Review with Evidence Tables

DESCRIPTION OF THE METHODS USED TO ANALYZE THE EVIDENCE

One or two topic leaders within a panel assume the responsibility of developing an evidence table for each clinical condition, based on analysis of the current literature. These tables serve as a basis for developing a narrative specific to each clinical condition.

METHODS USED TO FORMULATE THE RECOMMENDATIONS

Expert Consensus (Delphi)

DESCRIPTION OF METHODS USED TO FORMULATE THE RECOMMENDATIONS

Since data available from existing scientific studies are usually insufficient for meta-analysis, broad-based consensus techniques are needed for reaching agreement in the formulation of the appropriateness criteria. The American College of Radiology (ACR) Appropriateness Criteria panels use a modified Delphi technique to arrive at consensus. Serial surveys are conducted by distributing questionnaires to consolidate expert opinions within each panel. These questionnaires are distributed to the participants along with the evidence table and narrative as developed by the topic leader(s). Questionnaires are completed by the participants in their own professional setting without influence of the other members. Voting is conducted using a scoring system from 1 to 9, indicating the least to the most appropriate imaging examination or therapeutic procedure. The survey results are collected, tabulated in anonymous fashion, and redistributed after each round. A maximum of three rounds is conducted and opinions are unified to the highest degree possible. Eighty percent agreement is considered a consensus. This modified Delphi technique enables individual, unbiased expression, is economical, easy to understand, and relatively simple to conduct.

If consensus cannot be reached by this Delphi technique, the panel is convened and group consensus techniques are utilized. The strengths and weaknesses of each test or procedure are discussed and consensus reached whenever possible. If "No consensus" appears in the rating column, reasons for this decision are added to the comment sections.

RATING SCHEME FOR THE STRENGTH OF THE RECOMMENDATIONS

Not applicable

COST ANALYSIS

A formal cost analysis was not performed and published cost analyses were not reviewed.

METHOD OF GUIDELINE VALIDATION

Internal Peer Review

DESCRIPTION OF METHOD OF GUIDELINE VALIDATION

Criteria developed by the Expert Panels are reviewed by the American College of Radiology (ACR) Committee on Appropriateness Criteria.

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

ACR Appropriateness Criteria®

Clinical Condition: Breast Calcifications

Variant 1: Pleomorphic, fine, linear, branching in any distribution.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 9 CC and 90° lateral views preferred. Low
INV core biopsy breast 9   IP
X-ray mammography orthogonal views (90o lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. They will also be useful for pre-stereotactic localization or localization procedure. Low
Excisional biopsy breast 6 If discordant needle biopsy results or concerned about sampling error. If image guided percutaneous biopsy not available. None
US breast 4 May be useful in dense breast to look for mass component in lesion. None
MRI breast 3 Specific indications are still being investigated. None
X-ray diagnostic mammography 6-month follow-up 2   Low
INV fine needle aspiration breast 2   IP
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 2: Documentation of skin calcification.

Radiologic Procedure Rating Comments RRL*
X-ray mammography tangential views dermal localization exam 8 Only if calcifications are not typically dermal in appearance. Low
INV fine needle aspiration breast 1   IP
INV core biopsy breast 1   IP
Excisional biopsy breast 1   None
MRI breast 1   None
NUC sestamibi scan breast 1   High
X-ray mammography magnification views 1   Low
US breast 1   None
X-ray diagnostic mammography 6-month follow-up 1   Low
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 3: Milk of calcium, any distribution.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 8 CC and 90° lateral views preferred. Low
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. Low
X-ray diagnostic mammography 6-month follow-up 2   Low
INV fine needle aspiration breast 2   IP
Excisional biopsy breast 2   None
INV core biopsy breast 2   IP
US breast 2   None
MRI breast 1   None
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 4: Amorphous, single cluster.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 9 CC and 90° lateral views preferred. Low
INV core biopsy breast 8   IP
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. They will also be useful for pre-stereotactic localization or localization procedure. Low
Excisional breast biopsy 6 If discordant needle biopsy results or concerned about sampling error. If image guided percutaneous biopsy not available. None
X-ray diagnostic mammography 6-month follow-up 3 If present in retrospect and stable, 6-month follow-up can be considered. Low
MRI breast 2 Specific indications are still being investigated. None
US breast 2   None
INV fine needle aspiration breast 2   IP
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 5: Amorphous, multiple cluster, one breast.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 9 CC and 90° lateral views preferred. Low
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. They will also be useful for pre-stereotactic localization or localization procedure. Low
INV core biopsy breast 7 Sampling of representative grouping is recommended with further management dependent on histology. IP
Excisional biopsy breast 3   None
MRI breast 2 Specific indications are still being investigated. None
INV fine needle aspiration breast 2   IP
US breast 2   None
NUC sestamibi scan breast 1   High
X-ray diagnostic mammography 6-month follow-up No Consensus Some would only follow-up after work-up complete and biopsy of dominant cluster benign. Others would be more conservative. If no dominant cluster, they would do 6-month follow-up. Low
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 6: Amorphous, multiple bilateral clusters.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 8 CC and 90° lateral views preferred. Low
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. Low
X-ray diagnostic mammography 6-month follow-up 7 Once work-up demonstrates uniform, probably benign appearance of all calcifications. Low
MRI breast 2 Specific indications are still being investigated. None
Excisional biopsy breast 2   None
INV fine needle aspiration breast 2   IP
US breast 2   None
INV core biopsy breast 2   IP
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 7: Amorphous in a regional distribution.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 8 CC and 90° lateral views preferred. Low
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. They will also be useful for pre-stereotactic localization or localization procedure. Low
INV core biopsy breast 6   IP
MRI breast 2 Specific indications are still being investigated. None
INV fine needle aspiration breast 2   IP
Excisional biopsy breast 2   None
X-ray diagnostic mammography 6-month follow-up 2   Low
US breast 2   None
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 8: Amorphous in a linear or segmental distribution.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 9 CC and 90° lateral views preferred. Low
INV core biopsy breast 8   IP
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. They will also be useful for pre-stereotactic localization or localization procedure. Low
Excisional breast biopsy 6 If discordant needle biopsy results or concerned about sampling error. If image guided percutaneous biopsy not available. None
US breast 4 May be useful in dense breast to look for mass component in lesion. None
X-ray diagnostic mammography 6-month follow-up 2   Low
INV fine needle aspiration breast 2   IP
MRI breast 2 Specific indications are still being investigated. None
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 9: Course (popcorn), large rod-like, dystrophic, suture, lucent-centered, egg shell rim.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 2   Low
X-ray mammography orthogonal views 2   Low
US breast 2   None
X-ray diagnostic mammography 6-month follow-up 2   Low
INV fine needle aspiration breast 2   IP
INV core biopsy breast 2   IP
Excisional breast biopsy 2   None
MRI breast 2 Specific indications are still being investigated. None
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 10: Round or punctate, clustered.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 8 CC and 90° lateral views preferred. Low
X-ray diagnostic mammography 6-month follow-up 8 Biopsy if increasing Low
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. Low
INV core biopsy breast 4 Only if increasing. IP
Excisional biopsy breast 3   None
INV fine needle aspiration breast 2   IP
US breast 2   None
MRI breast 2 Specific indications are still being investigated. None
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 11: Round or punctate, regional.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 8 CC and 90° lateral views preferred. Low
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. Low
X-ray diagnostic mammography 6-month follow-up 6 If magnification views show calcifications that are probably benign. Low
Excisional biopsy breast 2   None
US breast 2   None
INV fine needle aspiration breast 2   IP
INV core biopsy breast 2   IP
MRI breast 2 Specific indications are still being investigated. None
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 12: Punctate calcifications in a linear or segmental distribution.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 8 CC and 90° lateral views preferred. Low
INV core biopsy breast 8   IP
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. They will also be useful for pre-stereotactic localization or localization procedure. Low
Excisional biopsy breast 6 If discordant needle biopsy results or concerned about sampling error. If image guided percutaneous biopsy not available. None
US breast 4 May be useful in dense breast to look for mass component in lesion. None
X-ray diagnostic mammography 6-month follow-up 2   Low
INV fine needle aspiration breast 2   IP
MRI breast 2 Specific indications are still being investigated. None
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 13: Punctate and amorphous, diffuse, bilateral.

Radiologic Procedure Rating Comments RRL*
INV fine needle aspiration breast 2   IP
INV core biopsy breast 2   IP
Excisional biopsy breast 2   None
MRI breast 2 Specific indications are still being investigated. None
X-ray mammography magnification views 2   Low
X-ray mammography orthogonal views 2   Low
X-ray diagnostic mammography 6-month follow-up 2   Low
US breast 2   None
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 14: Course heterogeneous, single cluster.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 8 CC and 90° lateral views preferred. Low
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. They will also be useful for pre-stereotactic localization or localization procedure. Low
INV core biopsy breast 6 If new or increasing. IP
X-ray diagnostic mammography 6-month follow-up 5 If magnification views demonstrate the calcifications to be probably benign. Low
Excisional biopsy breast 4 If suspicious and core not available. None
INV fine needle aspiration breast 2   IP
MRI breast 2 Specific indications are still being investigated. None
US breast 2   None
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 15: Course heterogeneous, multiple clusters, one breast.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 8 CC and 90° lateral views preferred. Low
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. Low
X-ray diagnostic mammography 6-month follow-up 7 If magnification views demonstrate the calcifications to be probably benign. Low
Excisional biopsy breast 2   None
MRI breast 2 Specific indications are still being investigated. None
US breast 2   None
INV fine needle aspiration breast 2   IP
INV core biopsy breast 2   IP
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 16: Course heterogeneous, multiple bilateral clusters.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 2   Low
X-ray mammography orthogonal views 2   Low
US breast 2   None
X-ray diagnostic mammography 6-month follow-up 2   Low
INV fine needle aspiration breast 2   IP
INV core biopsy breast 2   IP
Excisional biopsy breast 2   None
MRI breast 2 Specific indications are still being investigated. None
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 17: Course heterogeneous, in regional distribution.

Radiologic Procedure Rating Comments RRL*
X-ray mammography magnification views 8 CC and 90° lateral views preferred. Low
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. Low
X-ray diagnostic mammography 6-month follow-up 7 If magnification views demonstrate the calcifications to be probably benign. Low
INV core biopsy breast 4 If new or increasing. IP
US breast 3 If biopsy is contemplated and tissue is dense, may be useful to look for mass component in lesion. None
INV fine needle aspiration breast 2   IP
Excisional biopsy breast 2   None
MRI breast 2 Specific indications are still being investigated. None
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 18: Course heterogeneous, in linear or segmental distribution.

Radiologic Procedure Appropriateness Rating Comments RRL*
X-ray mammography magnification views 8 CC and 90° lateral views preferred. Low
INV core biopsy breast 8   IP
X-ray mammography orthogonal views (90° lateral and CC views if not readily available) 7 Orthogonal views may be useful in positioning for the spot compression magnification views to be sure to include the calcifications. They will also be useful for pre-stereotactic localization or localization procedure. Low
US breast 4 May be useful in dense breast to look for mass component in lesion. None
X-ray diagnostic mammography 6-month follow-up 2   Low
INV fine needle aspiration breast 2   IP
Excisional biopsy breast 2   None
MRI breast 2 Specific indications are still being investigated. None
NUC sestamibi scan breast 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Currently, ductal carcinoma-in-situ (DCIS) represents 25%-30% of all reported breast cancers. Approximately 95% of all DCIS is diagnosed because of mammographically detected microcalcifications. Prior to the widespread use of screening mammography, DCIS, detected as a mass on physical examination, was an uncommon disease representing less than 3% of all breast cancers. Screening mammography is the only reliable tool available for the detection of breast microcalcifications and DCIS.

Breast microcalcifications are detected commonly on screening mammograms. Most breast calcifications are benign and can be classified accordingly without any additional work-up. In women with indeterminate or malignant calcifications on screening studies, micro-focus (0.1 mm focal spot) magnification views in orthogonal projections are useful.

On magnification images, additional calcifications may be apparent, the morphology of individual calcifications can be characterized, and the distribution of calcifications can be better determined. In women with malignant calcifications, magnification images may be helpful in establishing the extent of disease.

Currently, the role for computer-aided detection (CAD) of calcifications has not yet been determined. However, recent studies indicate that computer-aided detection can be clinically useful to avoid false negatives when used properly.

Stereotactically guided core biopsy using a variety of devices can sample areas of microcalcifications. Stereotactically guided FNA of microcalcifications has been shown to be inaccurate. Core biopsy specimen radiographs should be done to establish the presence of calcifications in the core, as is done with surgically excised specimens.

Abbreviations

  • CC, cranial-caudal
  • FNA, fine needle aspiration
  • INV, invasive
  • IP, in progress
  • MRI, magnetic resonance imaging
  • NUC, nuclear medicine
  • US, ultrasound

Relative Radiation Level Effective Dose Estimated Range
None 0
Minimal <0.1 mSv
Low 0.1-1 mSv
Medium 1-10 mSv
High 10-100 mSv

CLINICAL ALGORITHM(S)

Algorithms were not developed from criteria guidelines.

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based on analysis of the current literature and expert panel consensus.

BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS

POTENTIAL BENEFITS

Selection of appropriate radiologic imaging procedures for the evaluation of patients with breast microcalcifications

POTENTIAL HARMS

Relative Radiation Level (RRL)

Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level indication has been included for each imaging examination. The RRLs are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure. Additional information regarding radiation dose assessment for imaging examinations can be found in the American College of Radiology (ACR) Appropriateness Criteria® Radiation Dose Assessment Introduction document (see "Availability of Companion Documents" field).

QUALIFYING STATEMENTS

QUALIFYING STATEMENTS

An American College of Radiology (ACR) Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists, and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient's clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those exams generally used for evaluation of the patient's condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the U.S. Food and Drug Administration (FDA) have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination.

IMPLEMENTATION OF THE GUIDELINE

DESCRIPTION OF IMPLEMENTATION STRATEGY

An implementation strategy was not provided.

IMPLEMENTATION TOOLS

Personal Digital Assistant (PDA) Downloads

For information about availability, see the "Availability of Companion Documents" and "Patient Resources" fields below.

INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES

IOM CARE NEED

Getting Better
Staying Healthy

IOM DOMAIN

Effectiveness

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • D'Orsi C, Bassett LW, Berg WA, Bohm-Velez M, Evans WP III, Farria DM, Lee C, Mendelson E, Goldstein S, Expert Panel on Women's Imaging. Breast microcalcifications. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 12 p. [17 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1996 (revised 2005)

GUIDELINE DEVELOPER(S)

American College of Radiology - Medical Specialty Society

SOURCE(S) OF FUNDING

The American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria®.

GUIDELINE COMMITTEE

Committee on Appropriateness Criteria, Expert Panel on Women's Imaging--Breast Work Group

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Panel Members: Carl D'Orsi, MD; Lawrence W. Bassett, MD; Wendie A. Berg, MD, PhD; Marcela Bohm-Velez, MD; W. Phil Evans III, MD; Dione Marie Farria, MD, MPH; Carol Lee, MD; Ellen Mendelson, MD; Steven Goldstein, MD

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

It updates a previously published version: Cardenosa G, Mendelson E, Bassett L, Bohm-Velez M, D'Orsi C, Evans WP 3rd, Monsees B, Thurmond A, Goldstein S. Appropriate imaging work-up of breast microcalcifications. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 Jun;215 Suppl:973-80.

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American College of Radiology (ACR) Web site.

ACR Appropriateness Criteria® Anytime, Anywhere™ (PDA application). Available from the ACR Web site.

Print copies: Available from the American College of Radiology, 1891 Preston White Drive, Reston, VA 20191. Telephone: (703) 648-8900.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on February 13, 2006.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo